- Home
- BMRN vs W Comparison
BMRN vs W Comparison
Compare BMRN & W Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | W |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 10.0B |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BMRN | W |
|---|---|---|
| Price | $54.55 | $71.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 28 |
| Target Price | $88.22 | ★ $105.82 |
| AVG Volume (30 Days) | 1.7M | ★ 3.2M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.15 |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $7.39 |
| Revenue Next Year | $12.23 | $6.00 |
| P/E Ratio | $31.27 | ★ N/A |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $24.45 |
| 52 Week High | $66.28 | $119.98 |
Technical Indicators
Market Signals| Indicator | BMRN | W |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 43.32 |
| Support Level | $53.71 | $70.59 |
| Resistance Level | $56.21 | $81.70 |
| Average True Range (ATR) | 1.33 | 4.52 |
| MACD | 0.13 | 0.30 |
| Stochastic Oscillator | 26.33 | 30.04 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About W Wayfair Inc.
Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 12 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.